(Q38600177)

4 September 2017

0 references

Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis (English)

1 reference

polycystic ovary syndrome

4 September 2017

main subject

1 reference

1 reference

1 reference

1 reference

1 reference

Li Feng

1

1 reference

4 September 2017

Xiao-Fang Lin

2

1 reference

4 September 2017

Zhi-Hua Wan

3

1 reference

4 September 2017

Dan Hu

4

1 reference

4 September 2017

Yu-Kai Du

5

1 reference

4 September 2017

language of work or name

1 reference

6 October 2015

1 reference

Gynecological Endocrinology

4 September 2017

published in

1 reference

4 September 2017

volume

31

1 reference

4 September 2017

issue

11

1 reference

4 September 2017

page(s)

833-839

1 reference

Polycystic ovaries and associated clinical and biochemical features in young women

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Prevalence of polycystic ovary syndrome in unselected women from southern China.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Preterm birth, an unresolved issue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Minimal brain dysfunction in children born in breech presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1041906

10.3109/09513590.2015.1041906

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference